Genoskin

Genoskin uses donated human skin samples that are kept alive to generate first-in-human clinical data in order to derisk drug, vaccine & compound development.

[Genoskin @Genoskin]

We’re live at #SIDChicago26!

Come meet the Genoskin team at our booth and discover how our ex vivo human skin platforms support dermatology research.

🧪 Stop by to chat with our experts
📍 Find us at booth #102

Looking forward to connecting with you!

[Genoskin @Genoskin]

Heading to #SIDChicago26? So are we!
Join Genoskin at the SID 83rd Annual Meeting and explore how human ex vivo skin models are advancing dermatology research.
📍 We will welcome you to our booth: #102
🧪 Don’t miss our poster presentations! Look for posters #0662 and #1038.

[Longevity Technology @LongevityTech]

Accelerating #antiaging trials using real human #skin...
@Genoskin can help de-risk antiaging trials with the only live human skin model available for subcutaneous administration testing.
#longevity #biotech
https://t.co/janhPnTeOn

[Genoskin @Genoskin]

📢 Publication alert! 📢 MANTIS® our groundbreaking analytic pipeline is published in @ScienceMagazine Advances! It revolutionizes immune phenotyping in skin samples, unraveling complex inflammatory conditions. https://t.co/g4430E8Afn #ScienceAdvances #Innovation #Immunology

[Genoskin @Genoskin]

https://t.co/XkcXDxTdCq

[Genoskin @Genoskin]

�� Very excited to announce the preprint of our #academic article on the MANTIS® #spatialbiology platform under the title: "3-D deconvolution of human skin #immune architecture with Multiplex Annotated Tissue Imaging System (MANTIS®)".
https://t.co/knWjViz6Sq

[Genoskin @Genoskin]

🐰 Happy #ChineseNewYear2023 to everyone! As serendipity will have it, 2023 is the year of the rabbit and therefore provides the perfect timing to focus on #animalfree #drug and #vaccine research!
Learn more here 👇
https://t.co/CGIruXB27h

[Genoskin @Genoskin]

🚨 If you're in the #Boston area, come meet our CSO and #immunology expert, Dr. Nicolas Gaudenzio!

🎯 He'll be in Kendall Sq. on Feb 2, 2023 to present our bio-stabilized skin model for high-dimensional #profiling of immune response to #injectable drugs.
https://t.co/QA6tbu7F2m

[Genoskin @Genoskin]

🙏 A huge thank you to all our amazing customers, donors, and teams in France and in the US, for an amazing 2022!
🎄Happy holidays to all! Here's to an even better 2023!
#thankyou

[Genoskin @Genoskin]

🎟 We’re delighted to announce that @Evotec Toulouse and Michael Esquerré, VP Immuno-Oncology, have invited Nicolas Gaudenzio, our CSO and Research Director of the @InsermOccPy Infinity Lab, for a live #evoseminar presentation at the Curie Campus in Toulouse on January 10th!

[Genoskin @Genoskin]

🚨 Last chance to register for tomorrow's @LeicaMicro #MicroscopyFocus #webinar with Dr Nicolas Gaudenzio, our CSO, on an easy way to perform 10+/- color #imaging of tissue samples to assess the skin #immune landscape.
Don't miss out !
https://t.co/ADXLBFl2xE

[Genoskin @Genoskin]

💡Discover a unique, simple method to perform 10+/-color #imaging of #tissue samples and assess the skin #immune landscape. Join Dr. Nicolas Gaudenzio for an exciting @LeicaMicro #MicroscopyFocus webinar on Dec. 7th 2022 to learn more. Register now! https://t.co/n6ajezKRCo

[Genoskin @Genoskin]

🎟 Last chance to meet the Genoskin team in the US this year! Come join Eric Merle, our Chief Business Innovation Officer, in #Boston next week, during the upcoming #LipidNanoparticles Immunogenicity & Toxicity Summit.
https://t.co/es9oUqqbed

[Genoskin @Genoskin]

🚀 Today is #spatialbiology day at the joint annual meeting of the @sfiimmunologie! Check out the #dataanalysis session in the Athena Auditorium (level 2) from 11:45 am to 1:15 pm and learn all about our MANTIS® #multiplex imaging solution!

[Genoskin @Genoskin]

🚨 Come join us at the 6th Annual #Dermatology Drug Development Summit for #Inflammatory Skin #Diseases in #Boston on November 2-3 and discover our unique solutions for dermatological #research and #DrugDevelopment!
https://t.co/8Eb2etpmfk

[Genoskin @Genoskin]

💡Come join Dr. Nicolas Gaudenzio, our Chief Scientific Officer, during the @crctoncopole #Workshop on Computational Analysis and #Multiomics in Oncology at the @IUCTOncopole auditorium in #Toulouse Monday, October 17. Don't miss out!
https://t.co/hvdGR23g23

[Genoskin @Genoskin]

🚨 New #jobalert in our labs in #Toulouse! If you hold a #PhD in #Immunology, Genoskin is actively #recruiting a Senior Study #Director. Come join our amazing team and help us accelerate and secure #DrugDevelopment!
Check out the job offer below👇
https://t.co/F0GxEnmzqF

[Genoskin @Genoskin]

🇪🇸 If you're at the #WVCEU @vaccinenation Congress in Barcelona, come meet the Genoskin team at booth # 1!
💉See how we evaluate #vaccine #efficacy and injection site #reactions after #subcutaneous and #intradermal injections or #transdermal patch administration. See you there!

[Genoskin @Genoskin]

🤔 Today’s #research on new #drugs is often complicated by a lack of relevant study tools.

💡 Genoskin now provides a reliable solution to help you #evaluate human primary #MastCell #response to your compound or formula.

Read more here 👇

https://t.co/Ppyn8teOFp

[Genoskin @Genoskin]

Un grand merci à @BFMTV de nous avoir invités pour l’émission Tech & Co hier! Genoskin est parmi les 4 finalistes (catégorie Santé) pour le #TechforGoodAwards cette année!
Découvrez l’#interview avec Eric Merle: https://t.co/hl3Lol46c3

@FRdigitale @bfmbusiness @TechForGoodBFM